Works by Ghamande, Sharad


Results: 10
    1

    Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-024-55200-2
    By:
    • Mayadev, Jyoti;
    • Zamarin, Dmitriy;
    • Deng, Wei;
    • Lankes, Heather A.;
    • Pesci, Giulio;
    • Kim, Hayeon;
    • Chino, Junzo P.;
    • Banbury, Barbara;
    • Sherry, Ned;
    • Sharon, Elad;
    • Ghamande, Sharad A.;
    • Ferguson, Catherine;
    • Mell, Loren;
    • Holman, Laura;
    • Mathews, Cara;
    • O'Malley, David;
    • Olawaiye, Alexander;
    • Hopp, Elizabeth;
    • Leath III, Charles;
    • Copeland, Larry
    Publication type:
    Article
    2
    3

    Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT‐OV26/GOG‐3012 trial.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 12, p. 1846, doi. 10.1002/cncr.34706
    By:
    • Mirza, Mansoor R.;
    • González‐Martín, Antonio;
    • Graybill, Whitney S.;
    • O'Malley, David M.;
    • Gaba, Lydia;
    • Stephanie Yap, Oi Wah;
    • Guerra, Eva M.;
    • Rose, Peter G.;
    • Baurain, Jean‐François;
    • Ghamande, Sharad A.;
    • Denys, Hannelore;
    • Prendergast, Emily;
    • Pisano, Carmela;
    • Follana, Philippe;
    • Baumann, Klaus;
    • Calvert, Paula M.;
    • Korach, Jacob;
    • Li, Yong;
    • Malinowska, Izabela A.;
    • Gupta, Divya
    Publication type:
    Article
    4
    5

    A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors.

    Published in:
    Investigational New Drugs, 2014, v. 32, n. 3, p. 445, doi. 10.1007/s10637-013-0044-7
    By:
    • Ghamande, Sharad;
    • Lin, Chia-Chi;
    • Cho, Daniel;
    • Shapiro, Geoffrey;
    • Kwak, Eunice;
    • Silverman, Michael;
    • Tseng, Yunlong;
    • Kuo, Min-Wen;
    • Mach, Wendy;
    • Hsu, Shu-Chi;
    • Coleman, Teresa;
    • Yang, James;
    • Cheng, Ann-Lii;
    • Ghalib, Mohammad;
    • Chuadhary, Imran;
    • Goel, Sanjay
    Publication type:
    Article
    6
    7
    8
    9

    Are There Survival Differences Between Women with Equivalent Residual Disease After Interval Cytoreductive Surgery Compared with Primary Cytoreductive Surgery for Advanced Ovarian and Peritoneal Cancer?

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 7, p. 3605, doi. 10.1245/s10434-020-09304-w
    By:
    • Mysona, David Pierce;
    • Ghamande, Sharad;
    • She, Jin-Xiong;
    • Tran, Lynn;
    • Tran, Paul;
    • Rungruang, Bunja J.;
    • Chan, John K.;
    • Bae-Jump, Victoria;
    • Gehrig, Paola A.
    Publication type:
    Article
    10